NVCR- Novocure Limited

Name: Novocure Limited Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Novocure Limited (NVCR) has 16 insiders with recent SEC Form 4 filings, including 4 buys and 8 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Cordova Ashley	437.6K	$7.36M	-
Dir	Danziger Asaf	416.5K	$7.01M	-
VP	Leonard Frank X	347.7K	$5.85M	-
Dir	Vernon W Anthony	179.1K	$3.01M	-
Other	Ben Arye Barak	174.5K	$2.94M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 4, 2026	Leupin Nicolas	Former Chief Medical Officer	Sell	1,100	$13.31	$14,635.94	-1.1%	-	-
Sep 5, 2025	Cordova Ashley75	Chief Executive Officer	Buy	81,550	$12.22	$996,859.05	+22.9%	-4.2%	-
Jul 29, 2025	Brackmann Christoph	Chief Financial Officer	Buy	20,000	$11.59	$231,800.00	+5.1%	+19.4%	-
Jun 3, 2025	Stafford Kristin	Director	Sell	999	$17.28	$17,258.92	-24.6%	-28.5%	-
Jun 3, 2025	Madden Martin J.	Director	Sell	999	$17.19	$17,175.61	-5.1%	-28.5%	-
Jun 3, 2025	Vernon W Anthony	Director	Sell	999	$17.35	$17,329.25	-0.6%	-28.5%	-
Jun 3, 2025	Ocean Allyson J	Director	Sell	999	$17.29	$17,269.01	-24.6%	-28.5%	-
Jun 3, 2025	Hilleman Jeryl L64	Director	Sell	999	$17.26	$17,246.54	-15.2%	-28.5%	-
Jun 3, 2025	Leung Gabriel82	Director	Sell	999	$17.31	$17,297.29	-1.2%	-28.5%	-
Jun 3, 2025	Hung David85	Director	Sell	999	$17.30	$17,279.50	-7.6%	-28.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC